Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan in Non-erosive Reflux Disease
NCT02556021Phase 3Completed
- Sponsor
- HK inno.N Corporation
- Start
- Sep 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tegoprazan in non-erosive reflux disease (NERD) (3 arms), sponsored by HK inno.N Corporation. Primary endpoint: Percentage of patients with complete resolution of main symptoms (heartburn and regurgitation) at 4-week. Started Sep 2015; status: completed.
02
Drugs
tegoprazan
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT02556021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556021.